Page 103 - MemoriaES-Eng

www.ciberes.org

• Donaire-Gonzalez D, Gimeno-Santos E, Balcells E, Rodríguez DA, Farrero E, de
Most relevant
Batlle J et al.. Physical activity in COPD patients: patterns and bouts.Eur Respir
scientific
J. 2013 Oct;42(4):993-1002.
articles
• Bazan V, Grau N, Valles E, Felez M, Sanjuas C, Cainzos-Achirica M. Obstructive
sleep apnea in patients with typical atrial flutter: prevalence and impact on arr-

hythmia control outcome.Chest. 2013 May;143(5):1277-83.

• Blanco I, Santos S, Gea J, Güell R, Torres F, Gimeno-Santos E et al.. Sildenafil

to improve respiratory rehabilitation outcomes in COPD: a controlled trial.Eur
Respir J. 2013 Oct;42(4):982-92.

• Barreiro E, Fermoselle C, Mateu-Jimenez M, Sánchez-Font A, Pijuan L, Gea J.
Oxidative stress and inflammation in the normal airways and blood of patients

with lung cancer and COPD.Free Radic Biol Med. 2013 Dec;65:859-71.

• Rubini Giménez M, Hoeller R, Reichlin T, Zellweger C, Twerenbold R, Reiter M.

Rapid rule out of acute myocardial infarction using undetectable levels of high-
sensitivity cardiac troponin.Int J Cardiol. 2013 Oct 9;168(4):3896-901.

Highlights
In 2013 our group has maintained its scientific outcomes, including original publi-
cations (20 Intl & 5 Ntl), reviews (4 Intl) and editorials (1 Intl & 3 Natl) in journals

of the highest impact factor in our specialty. Group members also have editorial

activities (editorship and editorial boards) from indexed journals (including Am
J Respir Crit Care Med & J Appl Physiol), and reviewers of 8 of them (including

N.Eng.J.Med). They are also reviewers of European projects (Horizon 2020) and

French, Belgian, Dutch and Spanish agencies.

Education: In the group, 2 doctoral and 4 master theses were defended in 2013,
and group members are actively engaged in teaching and management of under-

graduate and graduate studies (eg. direction of a master) .

The most interesting scientific results of 2013 are related to the molecular and
cellular events that occur in the muscles and bronchial airways of patients with

COPD and/or lung cancer.

The group has continued or completed competitive projects from Plan Nacional,

FIS, SEPAR and Maraton TV3, and 5 clinical trials. It has also obtained a FIS grant
for intensification.

Members of the group have also registered a patent related to respiratory thera-

pies (Controlizer©, nebulization), and participated in several clinical guidelines
and regulations: Statement of the American Thoracic Society and European Res-

piratory Society on muscle dysfunction in COPD; Guide to diagnosis and treatment

of lung cancer (SEPAR); Evaluation and clinical management of muscle dysfunc-
tion (SEPAR), whose documents will be published in high-class journals in 2014.
13
20
There are several active collaborations with international groups (Chicago, Ba- T
OR
sel, Maastricht) and participation in a working group of the National Institutes P
RE
of Health. At the National level, the group belongs to 4 stable multi-institutional L
networks (plus CIBERES).
A
NU
Finally, the group coordinator has been the Chair of the Annual Congress of the N
A
European Respiratory Society (Barcelona 2013).
S /
E
ER
B
CI

103